WOMB: a fetal monitoring wearable device

胎儿运动和胎儿健康之间有很强的联系：25%的孕妇感觉胎儿运动减少(RFM)会导致不良的围产儿结局。一项里程碑式的研究进一步表明，55%的死产发生在RFM之前。胎动监测和主观的产妇意识确实导致死产数量的减少，观察性研究表明，通过积极的管理，死产数量下降了30%。KYMIRA的成立旨在颠覆传统的医疗创新模式。使用先进的运动服装和新成立的医疗品牌，KYMIRA创造了容器，通过这些容器，它可以在健康和健身市场上商业化和验证未来的医疗技术。KYMIRA目前的活动包括开发、制造和销售其在国际上享有盛誉的红外线KYNERGY技术，并为体育和医疗市场开发可穿戴技术。这一后续研发项目将进一步开发KYMIRA用于长期监测和分析胎儿运动的新型纺织品传感器。胎儿运动是怀孕最后三个月健康状况的重要指标，该项目旨在提供新的可穿戴创新，以识别死产的前兆，并帮助减少死产的发生。

There is a strong link between fetal movement and fetal health: 25% of women perceiving reduced fetal movements (RFM) have poor perinatal outcomes. A landmark study has further shown that 55% of all stillbirths are preceded by RFM. Fetal movement monitoring and subjective maternal awareness does lead to a reduction in stillbirth numbers, with observational studies demonstrating a 30% fall in stillbirth numbers via proactive management.KYMIRA was founded to disrupt the traditional model of medical innovation. Using an advanced sportswear and newly formed medical brand, KYMIRA has created vessels through which it can commercialise and validate future medical technologies on the Health and Fitness market. KYMIRA's current activities include the development, manufacture and sale of their internationally-acclaimed infrared KYnergy technology, and developing wearable technologies for both the sports and healthcare markets.This follow-on R&D project will further the development of KYMIRA's novel textile-based sensors for long-term monitoring and analysis of fetal movements. Fetal movement is a vital indicator of wellbeing in the last trimester of pregnancy and this project aims to deliver new wearable innovations in order to identify precursors to and help reduce the occurrence of stillbirth.